Factorial Partners’s Bristol-Myers Squibb BMY Stock Holding History

Factorial Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-36,500	Closed	-$2.23M	–	64
2025 Q1	$2.23M	Hold	36,500	–	–	1.37%	32
2024 Q4	$2.06M	Hold	36,500	–	–	1.19%	36
2024 Q3	$1.89M	Buy	36,500 +1,500	+4%	+$70.4K	1.09%	36
2024 Q2	$1.45M	Sell	35,000 -6,000	-15%	-$268K	0.89%	43
2024 Q1	$2.22M	Sell	41,000 -1,000	-2%	-$50.9K	1.26%	36
2023 Q4	$2.16M	Sell	42,000 -8,100	-16%	-$425K	1.36%	32
2023 Q3	$2.91M	Sell	50,100 -8,100	-14%	-$496K	2.12%	14
2023 Q2	$3.72M	Buy	58,200 +6,400	+12%	+$429K	2.57%	9
2023 Q1	$3.59M	Buy	51,800 +7,500	+17%	+$529K	2.7%	6
2022 Q4	$3.19M	Buy	44,300 +20,400	+85%	+$1.54M	2.44%	14
2022 Q3	$1.7M	Sell	23,900 -1,900	-7%	-$138K	1.48%	22
2022 Q2	$1.99M	Sell	25,800 -13,600	-35%	-$1.04M	1.62%	21
2022 Q1	$2.88M	Sell	39,400 -32,900	-46%	-$2.21M	1.98%	16
2021 Q4	$4.51M	Buy	72,300 +6,000	+9%	+$352K	2.98%	5
2021 Q3	$3.92M	Buy	66,300 +6,300	+11%	+$415K	2.67%	10
2021 Q2	$4.01M	Hold	60,000	–	–	2.71%	7
2021 Q1	$3.79M	Buy	60,000 +22,800	+61%	+$1.42M	2.66%	5
2020 Q4	$2.31M	Buy	37,200 +5,550	+18%	+$341K	1.93%	15
2020 Q3	$1.91M	Buy	31,650 +250	+0.8%	+$15K	1.95%	17
2020 Q2	$1.85M	Buy	31,400 +20,300	+183%	+$1.21M	2.02%	13
2020 Q1	$619K	Sell	11,100 -3,800	-26%	-$232K	0.83%	41
2019 Q4	$956K	Buy	+14,900	New	+$853K	0.44%	75
2019 Q3	–	Sell	-13,200	Closed	-$599K	–	107
2019 Q2	$599K	Sell	13,200 -9,000	-41%	-$419K	0.57%	66
2019 Q1	$1.06M	Sell	22,200 -43,500	-66%	-$2.17M	1%	31
2018 Q4	$3.42M	Buy	65,700 +13,200	+25%	+$709K	3.58%	2
2018 Q3	$3.26M	Sell	52,500 -3,000	-5%	-$178K	2.8%	4
2018 Q2	$3.07M	Buy	+55,500	New	+$3M	2.75%	5

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Factorial Partners's BMY Position: Q2 2025 in Review

Factorial Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 36,500 shares — an estimated $2.23M sold.

Factorial Partners first reported a position in BMY in Q2 2018 and held it in 27 quarters. The position peaked at $4.51M in Q4 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Factorial Partners reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Factorial Partners sold 36,500 Bristol-Myers Squibb shares in Q2 2025, an estimated $2.23M.
Factorial Partners first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 27 quarters.
Factorial Partners's Bristol-Myers Squibb position peaked at $4.51M in Q4 2021.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Factorial Partners's 13F filing for Q2 2025, filed 11 Aug 2025.